Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.

Lee, V W Y

Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects. [electronic resource] - Journal of clinical pharmacy and therapeutics Jun 2010 - 343-50 p. digital

Publication Type: Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1365-2710

10.1111/j.1365-2710.2009.01088.x doi


2-Pyridinylmethylsulfinylbenzimidazoles--administration & dosage
Adult
Amoxicillin--administration & dosage
Anti-Bacterial Agents--administration & dosage
Anti-Ulcer Agents--administration & dosage
Aryl Hydrocarbon Hydroxylases--genetics
Asian People--genetics
Breath Tests--methods
Clarithromycin--administration & dosage
Cytochrome P-450 CYP2C19
Drug Resistance, Bacterial
Dyspepsia--drug therapy
Esomeprazole--administration & dosage
Female
Helicobacter Infections--drug therapy
Helicobacter pylori--drug effects
Hong Kong
Humans
Male
Middle Aged
Mutation
Pharmacogenetics
Polymorphism, Genetic
Prospective Studies
Rabeprazole
Urea--metabolism